BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27039396)

  • 1. Primaquine plus artemisinin combination therapy for reduction of malaria transmission: promise and risk.
    John CC
    BMC Med; 2016 Apr; 14():65. PubMed ID: 27039396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primaquine or other 8-aminoquinolines for reducing Plasmodium falciparum transmission.
    Graves PM; Choi L; Gelband H; Garner P
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD008152. PubMed ID: 29393511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission in Cambodia: An open-label randomized trial.
    Lin JT; Lon C; Spring MD; Sok S; Chann S; Ittiverakul M; Kuntawunginn W; My M; Thay K; Rahman R; Balasubramanian S; Char M; Lanteri CA; Gosi P; Ubalee R; Meshnick SR; Saunders DL
    PLoS One; 2017; 12(6):e0168702. PubMed ID: 28591198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal timing of primaquine to reduce Plasmodium falciparum gametocyte carriage when co-administered with artemether-lumefantrine.
    Shekalaghe S; Mosha D; Hamad A; Mbaga TA; Mihayo M; Bousema T; Drakeley C; Abdulla S
    Malar J; 2020 Jan; 19(1):34. PubMed ID: 31964380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial.
    Gonçalves BP; Tiono AB; Ouédraogo A; Guelbéogo WM; Bradley J; Nebie I; Siaka D; Lanke K; Eziefula AC; Diarra A; Pett H; Bougouma EC; Sirima SB; Drakeley C; Bousema T
    BMC Med; 2016 Mar; 14():40. PubMed ID: 26952094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
    Shekalaghe SA; ter Braak R; Daou M; Kavishe R; van den Bijllaardt W; van den Bosch S; Koenderink JB; Luty AJ; Whitty CJ; Drakeley C; Sauerwein RW; Bousema T
    Antimicrob Agents Chemother; 2010 May; 54(5):1762-8. PubMed ID: 20194698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Gametocytocidal Efficacy of Different Single Doses of Primaquine with Dihydroartemisinin-piperaquine in Asymptomatic Parasite Carriers in The Gambia: A Randomized Controlled Trial.
    Okebe J; Bousema T; Affara M; Di Tanna GL; Dabira E; Gaye A; Sanya-Isijola F; Badji H; Correa S; Nwakanma D; Van Geertruyden JP; Drakeley C; D'Alessandro U
    EBioMedicine; 2016 Nov; 13():348-355. PubMed ID: 27825738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single Low Dose Primaquine (0.25 mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient Subjects.
    Bancone G; Chowwiwat N; Somsakchaicharoen R; Poodpanya L; Moo PK; Gornsawun G; Kajeechiwa L; Thwin MM; Rakthinthong S; Nosten S; Thinraow S; Nyo SN; Ling CL; Wiladphaingern J; Kiricharoen NL; Moore KA; White NJ; Nosten F
    PLoS One; 2016; 11(3):e0151898. PubMed ID: 27010542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common.
    White NJ; Qiao LG; Qi G; Luzzatto L
    Malar J; 2012 Dec; 11():418. PubMed ID: 23237606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and tolerability of single low-dose primaquine in a low-intensity transmission area in South Africa: an open-label, randomized controlled trial.
    Raman J; Allen E; Workman L; Mabuza A; Swanepoel H; Malatje G; Frean J; Wiesner L; Barnes KI
    Malar J; 2019 Jun; 18(1):209. PubMed ID: 31234865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial.
    Mwaiswelo R; Ngasala B; Jovel I; Aydin-Schmidt B; Gosling R; Premji Z; Mmbando B; Björkman A; Mårtensson A
    Malar J; 2016 Aug; 15(1):435. PubMed ID: 27565897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model-based assessment of the safety of community interventions with primaquine in sub-Saharan Africa.
    van Beek SW; Svensson EM; Tiono AB; Okebe J; D'Alessandro U; Gonçalves BP; Bousema T; Drakeley C; Ter Heine R
    Parasit Vectors; 2021 Oct; 14(1):524. PubMed ID: 34627346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appropriate time for primaquine treatment to reduce Plasmodium falciparum transmission in hypoendemic areas.
    Wilairatana P; Krudsood S; Tangpukdee N
    Korean J Parasitol; 2010 Jun; 48(2):179-82. PubMed ID: 20585538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Plasmodium falciparum transmission with primaquine: same efficacy, improved safety with a lower dose?
    Chen IT; Gosling RD
    Expert Rev Clin Pharmacol; 2014 Nov; 7(6):681-6. PubMed ID: 25118908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gametocyte Clearance Kinetics Determined by Quantitative Magnetic Fractionation in Melanesian Children with Uncomplicated Malaria Treated with Artemisinin Combination Therapy.
    Karl S; Laman M; Moore BR; Benjamin J; Koleala T; Ibam C; Kasian B; Siba PM; Waltmann A; Mueller I; Woodward RC; St Pierre TG; Davis TM
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4489-96. PubMed ID: 25987625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term primaquine administration to reduce Plasmodium falciparum gametocyte transmission in hypoendemic areas.
    Wilairatana P; Tangpukdee N; Krudsood S
    Southeast Asian J Trop Med Public Health; 2010 Nov; 41(6):1306-11. PubMed ID: 21329302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination.
    Gerardin J; Eckhoff P; Wenger EA
    BMC Infect Dis; 2015 Mar; 15():144. PubMed ID: 25887935
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Pett H; Bradley J; Okebe J; Dicko A; Tiono AB; Gonçalves BP; Stone W; Chen I; Lanke K; Neuvonen M; Mustaniemi AL; Eziefula AC; Gosling R; D'Alessandro U; Drakeley C; Niemi M; Bousema T
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Efficacy of Adding a Single Low Dose of Primaquine to the Treatment of Adult Patients With Plasmodium falciparum Malaria in Senegal, to Reduce Gametocyte Carriage: A Randomized Controlled Trial.
    Tine RC; Sylla K; Faye BT; Poirot E; Fall FB; Sow D; Wang D; Ndiaye M; Ndiaye JL; Faye B; Greenwood B; Gaye O; Milligan P
    Clin Infect Dis; 2017 Aug; 65(4):535-543. PubMed ID: 28605472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a pharmacovigilance safety monitoring tool for the rollout of single low-dose primaquine and artemether-lumefantrine to treat Plasmodium falciparum infections in Swaziland: a pilot study.
    Poirot E; Soble A; Ntshalintshali N; Mwandemele A; Mkhonta N; Malambe C; Vilakati S; Pan S; Darteh S; Maphalala G; Brown J; Hwang J; Pace C; Stergachis A; Vittinghoff E; Kunene S; Gosling R
    Malar J; 2016 Jul; 15(1):384. PubMed ID: 27450652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.